Esteve Huayi Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is IBRUTINIB, with a corresponding US DMF Number 31679.
Remarkably, this DMF maintains an Active status since its submission on May 05, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 23, 2017, and payment made on May 08, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II